SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceuticals Stockholders Support Amended Transaction With Biota Holdings Limited at October 22nd Reconvened Special Meeting